Pharmaceuticals, Biotechnology and Life Sciences
US$46 million investment to establish wholly owned Puerto Rico subsidiary supporting U.S. manufacturing, supply security, and long-term growth of BESREMi®…
WESTMINSTER, Colo.–(BUSINESS WIRE)–TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology-focused medical technology company advancing novel drug…
Funding accelerates clinical development and market access across the U.S., Asia, and the Middle East BENGALURU, India & SAN CARLOS,…
Pioneering leader in de novo protein design strengthens its platform R&D, pipeline development, and global expansion SEOUL, South Korea–(BUSINESS WIRE)–#AIProteinDesign—Galux,…
PISCATAWAY, N.J.–(BUSINESS WIRE)–Kashiv BioSciences, LLC (“Kashiv”) a vertically integrated biopharmaceutical company, today announced that it has entered into an exclusive…
Taking place March 23-25, 2026, this three-day scientific forum will convene the world’s foremost NAD experts in Copenhagen to advance…
TOKYO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations globally, today…
LOS ANGELES–(BUSINESS WIRE)–Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunology therapies for dermatology, today…
Advisory Board provides independent guidance on strategic priorities, including growing adoption of the Company’s noninvasive CyPath® Lung diagnostic test SAN…
Initiates first-in-human clinical studies of an IgG-like CD3 bispecific designed with a wide therapeutic index to selectively redirect T cells…